Otezla (apremilast) is a brand-name oral tablet that’s prescribed for conditions such as psoriatic arthritis. The drug’s cost with and without insurance can depend on several factors, such as whether ...
Biopharmaceutical giant Amgen announced Monday it has agreed to buy popular psoriasis and psoriatic-arthritis drug Otezla from Celgene for $13.4 billion. The deal helps clear the way for Amgen’s ...
Amgen’s Otezla was the subject of a spoof pharma ad that ran during SNL’s most recent episode. The ad, featuring actor Ryan Gosling, poked fun at the supposed mystery behind the medication and its ...
With the Federal Trade Commission (FTC) sweating the details of Bristol-Myers Squibb and Celgene’s proposed $74 billion merger, all eyes were on the companies’ combined psoriasis portfolio, which ...
Otezla is the first oral therapy approved for moderate to severe plaque psoriasis in this patient population. The Food and Drug Administration (FDA) has expanded the approval of Otezla ® (apremilast) ...
(RTTNews) - Amgen (AMGN) agreed Monday to acquire worldwide rights to Otezla (apremilast), the only oral, non-biologic treatment for psoriasis and psoriatic arthritis, and certain related assets and ...
--Amgen today announced Otezla ® improved measures of disease severity in adults with mild-to-moderate plaque psoriasis regardless of their Body Surface Area affected by the disease, according to ...
Celgene’s Otezla may be waiting for a buyer, but that doesn't mean it has stopped expanding. The immunology med just nabbed a go-ahead in a niche market as the first FDA-approved therapy. Set aside ...
Celgene Corp(NASDAQ: CELG)launched Otezla in 2014 to diversify its revenue stream and by all measures, Celgene's first foray into autoimmune disease has been a success. Second quarter sales of Otezla ...
Amgen reported better-than-expected first-quarter results. The drugmaker said it plans to study psoriasis drug Otezla as a potential treatment for Covid-19. Otezla is a pill that helps reduce ...
THOUSAND OAKS, Calif., Aug. 20, 2024 /PRNewswire/ -- Amgen (AMGN) today announced Otezla ® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results